Skip to main content
Clinical Trials/PACTR202310744034060
PACTR202310744034060
Not yet recruiting
Phase 3

Safety And Efficacy Of Sublingual Versus Vaginal Misoprostol For Labour Induction Among Primigravida At Term: A Randomised Controlled Trial

Dr. Aituma Lewis Osadebamwen0 sites82 target enrollmentSeptember 30, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr. Aituma Lewis Osadebamwen
Enrollment
82
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 30, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Dr. Aituma Lewis Osadebamwen

Eligibility Criteria

Inclusion Criteria

  • Gestational age \=37 to 42 weeks.
  • Participants who have indication for induction of Labour.
  • Cervical assessment with Modified Bishops score value of less than 6\.
  • Singleton gestation.
  • Cephalic presentation.
  • Optimal biophysical profile.
  • Participants who gave written consent to participate in the study.

Exclusion Criteria

  • Teenage pregnancy.
  • Participants who withdraw consent even after being enrolled into the sudy.
  • All indications for Cesarean section.
  • Participants with relative or absolute contraindications to misoprostol use (e.g.; misoprostol allergies, Acute Cerebrovascular Disease, Coronary Artery Disease, epileptics).
  • A history of extensive uterine surgery.
  • Abnormal vaginal bleeding.
  • An unconscious patient.

Outcomes

Primary Outcomes

Not specified

Similar Trials